Neurogene Inc (NGNE)

10:30 AM

Can a trend reversal in Neurogene Inc. lead to recoveryWeekly Stock Recap & Growth Focused Entry Reports - newser.com

10:30 AM

10:07 AM

Price action breakdown for Neurogene Inc.Trade Volume Report & Capital Efficiency Focused Strategies - newser.com

10:07 AM

08:12 AM

How to track smart money flows in Neurogene Inc.July 2025 Big Picture & High Return Stock Watch Alerts - newser.com

08:12 AM

05:17 AM

Why Neurogene Inc. stock is popular among millennials2025 Big Picture & Advanced Swing Trade Entry Plans - newser.com

05:17 AM

02:22 AM

Does Neurogene Inc. qualify in momentum factor screeningProduct Launch & Reliable Price Action Trade Plans - newser.com

02:22 AM

12:19 PM

Why Neurogene Inc. stock remains a top recommendationQuarterly Market Summary & Verified Swing Trading Watchlist - newser.com

12:19 PM

Oct 12, 2025

Neurogene’s (NGNE) Buy Rating Reiterated at HC Wainwright - Defense World

Oct 12, 2025

Oct 10, 2025

HC Wainwright Reiterates Buy Rating for Neurogene (NASDAQ:NGNE) - MarketBeat

Oct 10, 2025

Oct 10, 2025

Neurogene (NASDAQ:NGNE) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat

Oct 10, 2025

Oct 10, 2025

How Neurogene Inc. (UU8) stock responds to job market shiftsJuly 2025 Sector Moves & High Win Rate Trade Tips - newser.com

Oct 10, 2025

Oct 09, 2025

HC Wainwright & Co. Reiterates Neurogene (NGNE) Buy Recommendation - Nasdaq

Oct 09, 2025

Oct 09, 2025

Neurogene Reaches Accord With FDA on Plan for Registrational Trial for Rett Syndrome Gene Therapy NGN-401 - CGTLive®

Oct 09, 2025

Oct 09, 2025

Neurogene Announces Positive Regulatory Update for NGN-401 Gene Therapy in Rett Syndrome with Plans to Initiate Dosing in Fourth Quarter of 2025 - MarketScreener

Oct 09, 2025

Oct 09, 2025

Neurogene to begin Rett syndrome gene therapy registrational trial in Q4 - Investing.com

Oct 09, 2025

Oct 09, 2025

Real time pattern detection on Neurogene Inc. stockQuarterly Trade Summary & Advanced Swing Trade Entry Alerts - newser.com

Oct 09, 2025

Oct 09, 2025

Neurogene Completes FDA Talks for Rett Syndrome Trial - TipRanks

Oct 09, 2025

Oct 09, 2025

Neurogene : Poster ESGCT2025 RoA Final Print - MarketScreener

Oct 09, 2025

Oct 09, 2025

23 developmental milestones — Neurogene to start Embolden dosing in Q4 2025 after FDA talks and ICV data - Stock Titan

Oct 09, 2025

Oct 09, 2025

What recovery options are there for Neurogene Inc.2025 Top Gainers & Low Risk Entry Point Guides - newser.com

Oct 09, 2025

Oct 09, 2025

Forecasting Neurogene Inc. price range with options dataTrade Exit Summary & Real-Time Stock Entry Alerts - newser.com

Oct 09, 2025

Oct 08, 2025

What drives Neurogene Inc UU8 stock priceBollinger Bands Signals & Free Explosive Wealth Accumulation - earlytimes.in

Oct 08, 2025

Oct 08, 2025

Neurogene to Participate in H.C. Wainwright Genetic Medicines Virtual Conference - Stock Titan

Oct 08, 2025

Oct 07, 2025

What analysts say about Neurogene Inc stockInflation Impact on Stocks & Big Data Market Reports - earlytimes.in

Oct 07, 2025

Oct 06, 2025

Short interest data insights for Neurogene Inc.July 2025 Highlights & Entry Point Confirmation Signals - newser.com

Oct 06, 2025

Oct 05, 2025

Is Neurogene Inc a good long term investmentWeekly Market Snapshot & Free Rapid Profit Acceleration - earlytimes.in

Oct 05, 2025

Oct 05, 2025

Neurogene Insiders Placed Bullish Bets Worth US$1.46m - simplywall.st

Oct 05, 2025

Oct 05, 2025

Strategies to average down on Neurogene Inc.Portfolio Performance Summary & Free Fast Gain Swing Trade Alerts - newser.com

Oct 05, 2025

Oct 05, 2025

Long term hold vs stop loss in Neurogene Inc.2025 Year in Review & Momentum Based Trading Ideas - newser.com

Oct 05, 2025

Oct 03, 2025

Neurogene announces inducement grants under Nasdaq Listing Rule - MarketScreener

Oct 03, 2025

Oct 03, 2025

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Oct 03, 2025

Oct 03, 2025

We're Not Very Worried About Neurogene's (NASDAQ:NGNE) Cash Burn Rate - 富途牛牛

Oct 03, 2025

Oct 03, 2025

Developing predictive dashboards with Neurogene Inc. dataQuarterly Market Review & Weekly Return Optimization Plans - newser.com

Oct 03, 2025

Oct 03, 2025

Does Neurogene Inc. stock trade at a discount to peersJuly 2025 Patterns & Free Community Consensus Stock Picks - newser.com

Oct 03, 2025

Oct 03, 2025

Is Neurogene Inc. trending in predictive chart modelsWeekly Trend Summary & Risk Controlled Daily Trade Plans - newser.com

Oct 03, 2025

Oct 02, 2025

Neurogene looks ‘deeply undervalued’ after Taysha news, says H.C. Wainwright - TipRanks

Oct 02, 2025

Oct 02, 2025

Batten Disease Pipeline 2025: Innovative Clinical Developments by 10+ Global Leaders – DelveInsight | Featuring Polaryx Therapeutics, Neurogene, Theranexus, M6P Therapeutics, Regenxbio - The Globe and Mail

Oct 02, 2025